BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36967458)

  • 1. Εmerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors.
    Evmorfopoulos K; Vlachostergios PJ; Sountoulides P; Tzortzis V
    Curr Cancer Drug Targets; 2023; 23(11):858-867. PubMed ID: 36967458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors.
    Urbini M; Bleve S; Schepisi G; Menna C; Gurioli G; Gianni C; De Giorgi U
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update.
    De Martino M; Chieffi P; Esposito F
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in Testicular Germ Cell Tumors: The Teratoma Challenge.
    Yodkhunnatham N; Pandit K; Puri D; Yuen KL; Bagrodia A
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs for testicular germ cell tumours: Contemporary indications for diagnosis, surveillance and follow-up.
    Chavarriaga J; Hamilton RJ
    Andrology; 2023 May; 11(4):628-633. PubMed ID: 36373757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of tumour markers in diagnosis and management of testicular germ cell tumours].
    Krege S; Albers P; Heidenreich A
    Urologe A; 2011 Mar; 50(3):313-21. PubMed ID: 21327901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
    Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
    Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
    Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond.
    Egan J; Salari K
    Urol Clin North Am; 2023 Feb; 50(1):133-143. PubMed ID: 36424077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours.
    Roška J; Lobo J; Ivovič D; Wachsmannová L; Mueller T; Henrique R; Jerónimo C; Chovanec M; Jurkovičová D
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential biomarkers for testicular germ cell tumour: Risk assessment, diagnostic, prognostic and monitoring of recurrence.
    Lakpour N; Saliminejad K; Ghods R; Reza Sadeghi M; Pilatz A; Khosravi F; Madjd Z
    Andrologia; 2021 May; 53(4):e13998. PubMed ID: 33534171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testicular germ cell tumor: a comprehensive review.
    Batool A; Karimi N; Wu XN; Chen SR; Liu YX
    Cell Mol Life Sci; 2019 May; 76(9):1713-1727. PubMed ID: 30671589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors.
    Schmidtova S; Kalavska K; Kucerova L
    Curr Oncol Rep; 2018 Sep; 20(11):88. PubMed ID: 30259297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Kawai T; Tanaka Y;
    Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.
    Cierna Z; Mego M; Miskovska V; Machalekova K; Chovanec M; Svetlovska D; Hainova K; Rejlekova K; Macak D; Spanik S; Ondrus D; Kajo K; Mardiak J; Babal P
    Ann Oncol; 2016 Feb; 27(2):300-5. PubMed ID: 26598537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stroll through the present and future of testicular germ cell tumour biomarkers.
    Tavares NT; Henrique R; Bagrodia A; Jerónimo C; Lobo J
    Expert Rev Mol Diagn; 2023 May; 23(5):405-418. PubMed ID: 37088989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Overview on Predictive Biomarkers of Testicular Germ Cell Tumors.
    Chieffi P
    J Cell Physiol; 2017 Feb; 232(2):276-280. PubMed ID: 27405110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tumour markers in germ cell tumours: From diagnosis to cure.
    Pedrazzoli P; Rosti G; Soresini E; Ciani S; Secondino S
    Crit Rev Oncol Hematol; 2021 Mar; 159():103224. PubMed ID: 33493632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications.
    Kalavska K; Conteduca V; De Giorgi U; Mego M
    Curr Cancer Drug Targets; 2018; 18(10):967-978. PubMed ID: 29295694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biology of testicular germ cell tumors.
    Gonzalez-Exposito R; Merino M; Aguayo C
    Clin Transl Oncol; 2016 Jun; 18(6):550-6. PubMed ID: 26482724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.